Turmeric: 1,489 Peer-Reviewed Biomedical Studies Supporting Its Use as a Medicine


Its official!  We have just completed our two week long project of reviewing all 3,866 studies on Turmeric (and its major phenolic compound curcumin) on MEDLINE and we have published our results on the GreenMedInfo.com Turmeric page.  We believe that this page (which will take a minute to load, due to the voluminosity of data) is the worlds’ most extensive biomedical resource on the subject of this herb’s benefits and we encourage you to share it with others and link to it.

We have found no less than 1489 studies indexed across 152 pharmacological actions indicating its therapeutic value in the prevention or treatment of 564 Diseases.  All of these are now freely available on our database.

Below you will find a screenshot showing the top diseases (37 visible) that Turmeric compounds that the evidence demonstrates have therapeutic value in preventing or treating.*

We determine these disease rankings according to both the number and quality of studies that exist supporting its use.  We call this rating  “evidence density,” and it attributes greater value to human, animal, and test tube (in vitro) studies, in that descending order. (Click here to learn more about evidence density)

As you can see there are 168 studies indicating it has antioxidant activity, 29 on its potential value for Alzheimer disease, and 51 on its value for inflammation.


*Due to the FDA’s unconstitutional gag order against our first amendment right to speak truthfully about the science indicating the therapeutic value of natural substances in disease prevention and treatment, we have created an algorithm which generates a statement about a substance’s “evidence density” based on the quantity and quality of research on our database that exists to support it.  To learn more about evidence density go here.

Related Substance – Curcumin
Quick Summary: 564 Diseases
Name Evidence Density Article Count Focus Articles
Oxidative Stress 242 168 select
Alzheimer Disease 55 29 select
Inflammation 50 51 select
Liver Fibrosis 46 30 select
Cancers: Drug Resistant 45 42 select
Pancreatic Cancer 45 24 select
Chemically-Induced Liver Damage 44 32 select
Breast Cancer 43 61 select
Prostate Cancer 43 42 select
Lung Cancer 42 39 select
Colorectal Cancer 38 23 select
DNA damage 37 52 select
Colon Cancer 31 52 select
Pulmonary Fibrosis 30 12 select
Cancer Metastasis 29 35 select
Diabetes Mellitus: Type 2 29 19 select
Memory Disorders 28 13 select
Cancers: All 26 28 select
Colitis 26 17 select
Inflammatory Bowel Diseases 26 12 select
Endothelial Dysfunction 25 15 select
Lipopolysaccharide-Induced Toxicity 25 35 select
Tumors 25 25 select
Aflatoxicosis 22 16 select
Lipid Peroxidation 21 37 select
Osteoarthritis 21 9 select
Parkinsonism 21 2 select
Arsenic Poisoning 20 10 select
Cancers: Multi-Drug Resistant 19 26 select
Diabetes: Cardiovascular Illness 19 11 select
Multiple Myeloma 19 11 select
Bladder Cancer 18 16 select
Neurodegenerative Diseases 18 13 select
Aging 17 11 select
Brain Ischemia 17 11 select
High Cholesterol 17 9 select
Irritable Bowel Syndrome 17 6 select
Liver Cancer 17 24 select
Melanoma 17 22 select
Chemotherapy-Induced Toxicity: Bleomycin 16 8 select
Dementia 16 4 select
Insulin Resistance 16 9 select
Diabetes Mellitus: Type 1 15 9 select
Arthritis: Rheumatoid 14 6 select
Coronary Artery Disease 14 3 select
Diabetic Retinopathy 14 4 select
Endotoxemia 14 8 select
Glioma 14 13 select
Hyperthyroidism 14 5 select
Leukemia 14 23 select
Parkinson Disease 14 10 select
Quick Summary: 152 Pharmacological Actions
Name Evidence Density Article Count Focus Articles
Apoptotic 297 305 select
Antioxidants 276 226 select
Antineoplastic Agents 216 257 select
Neuroprotective Agents 197 110 select
NF-kappaB inhibitor 186 183 select
Antiproliferative 177 202 select
Anti-Inflammatory Agents 122 80 select
Tumor Necrosis Factor (TNF) Alpha Inhibitor 117 87 select
Hepatoprotective 104 80 select
Enzyme Inhibitors 91 95 select
Chemopreventive 57 75 select
Cell cycle arrest 56 90 select
Cyclooxygenase 2 Inhibitors 52 57 select
Cardioprotective 43 36 select
Chemosensitizer 42 48 select
Renoprotective 42 31 select
Interleukin-6 downregulation 39 22 select
Anti-Angiogenic 36 33 select
Anticarcinogenic Agents 33 73 select
Hypolipidemic 33 14 select
Matrix metalloproteinase-2 (MMP-2) inhibitor 26 24 select
Anti-metastatic 25 31 select
Interleukin-1 beta downregulation 24 17 select
Vascular Endothelial Growth Factor A Inhibitor 22 19 select
Tumor Suppressor Protein p53 Upregulation 21 34 select
Radiosensitizer 19 14 select
Anti-Proliferative 16 15 select
Hypoglycemic Agents 15 11 select
Anti-Fibrotic 14 13 select
Proteasome Inhibitors 13 11 select
Anticonvulsants 12 6 select
Gastroprotective 12 8 select
Immunomodulatory 12 13 select
Analgesics 11 5 select
Matrix metalloproteinase-3 (MMP-3) inhibitor 11 6 select
Antiviral Agents 10 14 select
Matrix metalloproteinase-9 (MMP-9) inhibitor 10 10 select
Anti-Bacterial Agents 9 13 select
Anti-Ulcer Agents 8 6 select
Nitric Oxide Inhibitor 8 12 select
Transforming growth factor beta (TGF-β) inhibitor 8 3 select
Interleukin-10 downregulation 7 6 select
Interleukin-8 downregulation 7 9 select
Prostaglandin PGE2 downregulation 7 11 select
Radioprotective 7 22 select
Anti-Allergic Agents 6 8 select
Antiparasitic Agents 6 4 select
Bcl-2 protein down-regulation 6 8 select
Genoprotective 6 17 select
Anti-Apoptotic 5 5 select
Anti-Platelet 5 4 select
10 select

 

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a comment